Green tea extract decreases muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx mice

Clinical Nutrition

Volumn 29, Issue 3, 2010, Pages 391-398

  Evans, Nicholas P ^a   Call, Jarrod A ^b   Bassaganya Riera, Josep ^c   Robertson, John L ^a   Grange, Robert W ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Duchenne muscular dystrophy; Green tea extract; Mdx; Muscle histopathology; Muscle regeneration; NF B

Indexed keywords

CREATINE KINASE; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; PLANT EXTRACT; TEA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; C57BL 6 MOUSE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; GENOTYPE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; MUSCLE CELL; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; AGING; ANIMAL; BLOOD; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MUSCULAR DYSTROPHY, DUCHENNE; NECROSIS; PATHOLOGY; PHYTOTHERAPY; PREGNANCY; PRENATAL EXPOSURE; RANDOMIZATION; REGENERATION; SKELETAL MUSCLE; TEA;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACROPHAGES; MALE; MICE; MICE, INBRED MDX; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NECROSIS; NF-KAPPA B; PHYTOTHERAPY; PLANT EXTRACTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; REGENERATION; TEA;

EID: 77953537515     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.10.001     Document Type: Article

References (39)

1. Blake D.J., Weir A., Newey S.E., Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002, 82:291-329.
2. Tidball J.G., Wehling-Henricks M. Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr Res 2004, 56:831-841.
3. Porter J.D., Guo W., Merriam A.P., Khanna S., Cheng G., Zhou X., et al. Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord 2003, 13:223-235.
4. Porter J.D., Khanna S., Kaminski H.J., Rao J.S., Merriam A.P., Richmonds C.R., et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002, 11:263-272.
5. Spencer M.J., Tidball J.G. Do immune cells promote the pathology of dystrophin-deficient myopathies?. Neuromuscul Disord 2001, 11:556-564.
6. Spencer M.J., Walsh C.M., Dorshkind K.A., Rodriguez E.M., Tidball J.G. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J Clin Invest 1997, 99:2745-2751.
7. Wehling M., Spencer M.J., Tidball J.G. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 2001, 155:123-132.
8. Villalta S.A., Nguyen H.X., Deng B., Gotoh T., Tidball J.G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 2009, 18:482-496.
9. Valcic S., Muders A., Jacobsen N.E., Liebler D.C., Timmermann B.N. Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals. Chem Res Toxicol 1999, 12:382-386.
10. Chen P.C., Wheeler D.S., Malhotra V., Odoms K., Denenberg A.G., Wong H.R. A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 2002, 26:233-241.
11. Feng W.Y. Metabolism of green tea catechins: an overview. Curr Drug Metab 2006, 7:755-809.
12. Dorchies O.M., Wagner S., Vuadens O., Waldhauser K., Buetler T.M., Kucera P., et al. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol 2006, 290:C616-C625.
13. Qin J., Xie L.P., Zheng X.Y., Wang Y.B., Bai Y., Shen H.F., et al. A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun 2007, 354:852-857.
14. Sen P., Chakraborty P.K., Raha S. Tea polyphenol epigallocatechin 3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFkappaB survival pathways. FEBS Lett 2006, 580:278-284.
15. Yang F., Oz H.S., Barve S., de Villiers W.J., McClain C.J., Varilek G.W. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001, 60:528-533.
16. Liu H.S., Chen Y.H., Hung P.F., Kao Y.H. Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway. Am J Physiol Endocrinol Metab 2006, 290:E273-E281.
17. Sah J.F., Balasubramanian S., Eckert R.L., Rorke E.A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004, 279:12755-12762.
18. Zhang Q., Kelly A.P., Wang L., French S.W., Tang X., Duong H.S., et al. Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways. J Invest Dermatol 2006, 126:2607-2613.
19. Rando T.A. Role of nitric oxide in the pathogenesis of muscular dystrophies: a " two hit" hypothesis of the cause of muscle necrosis. Microsc Res Tech 2001, 55:223-235.
20. Whitehead N.P., Yeung E.W., Allen D.G. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol 2006, 33:657-662.
21. Disatnik M.H., Dhawan J., Yu Y., Beal M.F., Whirl M.M., Franco A.A., et al. Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci 1998, 161:77-84.
22. Buetler T.M., Renard M., Offord E.A., Schneider H., Ruegg U.T. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 2002, 75:749-753.
23. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
24. Monici M.C., Aguennouz M., Mazzeo A., Messina C., Vita G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 2003, 60:993-997.
25. Acharyya S., Villalta S., Bakkar N., Bupha-Intr T., Janssen P., Carathers M., et al. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007, 117:889-901.
26. Grounds M.D., Torrisi J.O. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 2004, 18:676-682.
27. Hodgetts S., Radley H., Davies M., Grounds M.D. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscul Disord 2006, 16:591-602.
28. Messina S., Altavilla D., Aguennouz M., Seminara P., Minutoli L., Monici M.C., et al. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am J Pathol 2006, 168:918-926.
29. Messina S., Bitto A., Aguennouz Mh, Minutoli L., Monici M.C., Altavilla D., et al. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 2006, 198:234-241.
30. Nakae Y., Hirasaka K., Goto J., Nikawa T., Shono M., Yoshida M., et al. Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study. Histochem Cell Biol 2008, 129:489-501.
31. Radley H.G., Grounds M.D. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiol Dis 2006, 23:387-397.
32. Stupka N., Gregorevic P., Plant D.R., Lynch G.S. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice. Acta Neuropathol 2004, 107:299-310.
33. Couteaux R., Mira J.C., d'Albis A. Regeneration of muscles after cardiotoxin injury. I. Cytological aspects. Biol Cell 1988, 62:171-182.
34. Morioka S., Goto K., Kojima A., Naito T., Matsuba Y., Akema T., et al. Functional overloading facilitates the regeneration of injured soleus muscles in mice. J Physiol Sci 2008, 58:397-404.
35. Salvini T.F., Morini C.C., Selistre de Araujo H.S., Ownby C.L. Long-term regeneration of fast and slow murine skeletal muscles after induced injury by ACL myotoxin isolated from Agkistrodon contortrix laticinctus (broad-banded copperhead) venom. Anat Rec 1999, 254:521-533.
36. Totsuka T., Watanabe K., Uramoto I., Sakuma K., Mizutani T. Muscular dystrophy: centronucleation may reflect a compensatory activation of defective myonuclei. J Biomed Sci 1998, 5:54-61.
37. Pan Y., Chen C., Shen Y., Zhu C.H., Wang G., Wang X.C., et al. Curcumin alleviates dystrophic muscle pathology in mdx mice. Mol Cells 2008, 25:531-537.
38. Whitehead N.P., Pham C., Gervasio O.L., Allen D.G. N-acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 2008, 586:2003-2014.
39. Call J.A., Voelker K.A., Wolff A.V., McMillan R.P., Evans N.P., Hulver M.W., et al. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. J Appl Physiol 2008, 105:923-932.